- Corporate Officers - H
- Hykes Kevin
Insider Trading History of Hykes Kevin
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hykes Kevin since 2013.
This trader's CIK number is 1467748.
At the time of last reporting, Hykes Kevin was the PRES & CEO of Cvrx, Inc.. (stock ticker symbol CVRX).
Also see all insider trading activities at Cvrx, Inc..
Note that in the past
Hykes Kevin also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Cvrx, Inc. (CVRX) by Hykes Kevin
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | CVRX | 5,000 | $24,200 | 0 | $0 | 0 | $0 |
2024 | CVRX | 30,000 | $250,770 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Hansen Medical Inc (HNSN) by Hykes Kevin
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2014 | HNSN | 0 | $0 | 0 | $0 | 22,764 | $25,723 |
2013 | HNSN | 35,955 | $47,501 | 0 | $0 | 0 | $0 |
Insider trading activities at 2 companies by Hykes Kevin:
1. Cvrx, Inc. (CVRX)
2. Hansen Medical Inc (HNSN)
Table 1. Insider trading of Cvrx, Inc. (CVRX) by Hykes Kevin
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-05-12 | CVRX | Buy | 5,000 | 4.84 | 24,200 |
2024-08-05 | CVRX | Buy | 30,000 | 8.36 | 250,770 |
Table 2. Insider trading of Hansen Medical Inc (HNSN) by Hykes Kevin
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2014-08-25 | HNSN | Option Ex | 22,764 | 1.13 | 25,723 |
2013-07-30 | HNSN | Buy | 28,455 | 1.23 | 34,999 |
2013-05-13 | HNSN | Buy | 7,500 | 1.67 | 12,502 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Hykes Kevin
(PRES & CEO of Cvrx, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.